https://cdalab.cl/healthy-longevity-global-grand-challenge-nam22i0007-blood-borne-components-from-pregnant-females-novel-therapeutic-avenue-against-alzheimers-disease-2022-2023-2/2024-11-17T16:45:51+00:00https://cdalab.cl/fondef-idea-id22i10029-neureka-latam-self-administered-neurocognitive-assessment-mobile-app-for-dementia-diagnosis-in-chilean-older-adults-2022-2024-2/2022-12-14T06:40:23+00:00https://cdalab.cl/fondecyt-1210622-contribution-of-peripheral-tau-aggregates-to-alzheimers-disease-pathogenesis-2021-2025-2/2022-11-25T07:32:50+00:00https://cdalab.cl/anillo-act210096-machine-learning-for-mental-health-new-developments-and-applications-using-multimodal-data-2021-2024-2/2022-11-25T07:33:52+00:00https://cdalab.cl/fondef-20i10152-machine-learning-early-diagnosis-multimodal-profile-alzheimers-disease-based-on-mirna-circulating-exosome-2020-2022/2024-11-17T17:24:50+00:00https://cdalab.cl/fondecyt-1190958-cancer-leaves-trait-diminished-immune-tolerance-that-protects-alzheimers-disease-2019-2023-2/2024-11-17T17:25:34+00:00https://cdalab.cl/fondecyt-1200880-contribution-of-the-unfolded-protein-response-signaling-to-retinal-neural-circuits-function-during-aging-and-neurodegeneration-2020-2024-2/2022-11-25T07:46:55+00:00https://cdalab.cl/fondef-20i10252-effective-immunotherapy-treatment-alzheimers-disease-pre-clinical-trial-2020-2022-2/2024-11-17T17:27:13+00:00https://cdalab.cl/brainlat-seed-grant-transcriptomic-characterization-circulating-cell-free-mrna-in-latin-american-patients-with-alzheimers-disease-and-frontotemporal-dementia-2021-2/2024-11-17T17:28:25+00:00https://cdalab.cl/alzheimers-drug-discovery-foundation-and-target-als-foundation-us-r-202203-2023090-machine-learning-for-the-diagnosis-and-multimodal-profile-of-neurodegenerative-diseases-based-on-mirna-circula-2/2022-11-25T07:51:19+00:00https://cdalab.cl/research-asisstants/2022-11-25T07:55:36+00:00https://cdalab.cl/students/2022-11-25T07:56:24+00:00https://cdalab.cl/internships/2022-11-25T07:57:07+00:00https://cdalab.cl/postdoctoral-fondecyt-grant-3140466-regulation-of-an-ad-like-process-by-the-upr-transcription-factor-xbp1-in-vivo-role-principal-investigator-2014-2016/2022-11-25T08:25:32+00:00https://cdalab.cl/conicyt-brazil-cooperation-grant-441921-2016-7-disrupted-proteostasis-as-a-shared-mechanism-of-cognitive-decline-in-normal-aging-and-alzheimers-disease-role-associated-investigator-201/2022-11-25T08:26:12+00:00https://cdalab.cl/fondef-id16i10223-proteostaser-1-una-terapia-genica-enfocada-a-disminuir-la-neurodegeneracion-y-aumentar-la-funcion-cognitiva-en-la-enfermedad-de-alzheimer-role-associated-investigator-2016-20/2022-11-25T08:27:45+00:00https://cdalab.cl/fondecyt-11160760-targeting-the-er-stress-sensor-ire1-to-treat-alzheimers-disease-role-principal-investigator-2016-2019/2022-11-25T08:28:49+00:00https://cdalab.cl/conicyt-usa-cooperation-grant-redi170583-investigacion-traslacional-en-enfermedades-neurodegenerativas-y-envejecimiento-estudio-de-factores-de-riesgo-y-biomarcadores-inflamatorios-role-principal/2022-11-25T08:33:52+00:00https://cdalab.cl/alzheimers-association-2018-aarg-591107-targeting-the-upr-stress-sensor-ire1-to-treat-alzheimers-disease-role-principal-investigator-2018-2021/2022-11-25T08:34:41+00:00